Clinical usage of serum ferritin to assess liver fibrosis in patients with non-alcoholic fatty liver disease: Proceed with caution

Hepatology Research

Volumn 44, Issue 14, 2014, Pages E499-E502

  Yoneda, Masato ^a,c   Thomas, Emmanuel ^a   Sumida, Yoshio ^b   Imajo, Kento ^c   Eguchi, Yuichiro ^d   Hyogo, Hideyuki ^e   Fujii, Hideki ^f   Ono, Masafumi ^g   Kawaguchi, Takumi ^h   Schiff, Eugene R ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d SAGA UNIVERSITY   (Japan)

^e HIROSHIMA UNIVERSITY   (Japan)

^f OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^g KOCHI MEDICAL SCHOOL   (Japan)

^h KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Fibrosis; Non alcoholic fatty liver disease; Non alcoholic steatohepatitis; Serum ferritin

Indexed keywords

FERRITIN;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; FEMALE; FERRITIN BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; JAPANESE (PEOPLE); LIVER CELL; LIVER FIBROSIS; LIVER HISTOLOGY; MAJOR CLINICAL STUDY; MALE; MOLECULAR DIAGNOSIS; NONALCOHOLIC FATTY LIVER; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE;

EID: 84918573697     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/hepr.12327     Document Type: Article

References (12)

1. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002; 18: 1221-1231.
2. Liou I, Kowdley KV. Natural history of nonalcoholic steatohepatitis. J Clin Gastroenterol 2006; 40 (Suppl 1): S11-16.
3. George DK, Goldwurm S, MacDonald GA etal. Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. Gastroenterology 1998; 114: 311-318.
4. Yoneda M, Nozaki Y, Endo H etal. Serum ferritin is a clinical biomarker in Japanese patients with nonalcoholic steatohepatitis (NASH) independent of HFE gene mutation. Dig Dis Sci 2010; 55: 808-814.
5. Kowdley KV, Belt P, Wilson LA etal. Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease. Hepatology 2012; 55: 77-85.
6. Angulo P, George J, Day CP etal. Serum ferritin levels lack diagnostic accuracy for liver fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 2013; [Epub ahead of print].
7. Yoneda M, Fujii H, Sumida Y etal. Platelet count for predicting fibrosis in nonalcoholic fatty liver disease. J Gastroenterol 2011; 46: 1300-1306.
8. Brunt EM, Janney CG, Di Bisceglie AM etal. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999; 94: 2467-2474.
9. Kleiner DE, Brunt EM, Van Natta M etal. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005; 41: 1313-1321.
10. Sumida Y, Yoneda M, Hyogo H etal. A simple clinical scoring system using ferritin, fasting insulin, and type IV collagen 7S for predicting steatohepatitis in nonalcoholic fatty liver disease. J Gastroenterol 2011; 46: 257-268.
11. Mendler MH, Turlin B, Moirand R etal. Insulin resistance-associated hepatic iron overload. Gastroenterology 1999; 117: 1155-1163.
12. Iwasaki T, Nakajima A, Yoneda M etal. Serum ferritin is associated with visceral fat area and subcutaneous fat area. Diabetes Care 2005; 28: 2486-2491.